Skip to main content

Table 4 Validation of predictive factors for TIA (n = 377; number of events = 92)

From: Association of serum levels of antibodies against ALDOA and FH4 with transient ischemic attack and cerebral infarction

   Agec HT DM Age + HT Age + DM HT + DM Age + HT + DM
Single risk TIA ( +) 73 60 27 53 25 21 21
TIA (-) 79 57 11 28 5 5 2
PPVd 48.0% 51.3% 71.1% 65.4% 83.3% 80.8% 91.3%
Single risk + ALDOA-Aba TIA ( +) 53 47 21 41 20 17 17
TIA (-) 31 27 2 12 1 0 0
PPV 63.1% 63.5% 91.3% 77.4% 95.2% 100.0% 100.0%
Single risk + FH-Abb TIA ( +) 39 33 16 29 14 14 13
TIA (-) 24 25 1 12 0 1 0
PPV 61.9% 56.9% 94.1% 70.7% 100.0% 93.3% 100.0%
Single risk + ALDOA-Ab + FH-Ab TIA ( +) 32 29 15 25 14 13 13
TIA (-) 11 14 0 7 0 0 0
PPV 74.4% 67.4% 100.0% 78.1% 100.0% 100.0% 100.0%
  1. aADOLA-Ab, elevated ADOLA-Ab levels, > 14,869
  2. bFH-Ab, elevated FH-Ab levels, > 2,849
  3. cAge, ≥ 60
  4. dPPV, positive predictive value
Back to article page

BMC Neurology

ISSN: 1471-2377

Contact us